Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia

American Journal of Clinical Nutrition

Volumn 63, Issue 5, 1996, Pages 687-697

  Carlson, Susan E ^a,b   Werkman, Susan H ^a   Tolley, Elizabeth A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Newborn Center   (United States)

Author keywords

arachidonic acid; bronchopulmonary dysplasia; docosahexaenoic acid; eicosapentaenoic acid; growth; Linolenic acid; preterm infants; visual acuity

Indexed keywords

ARACHIDONIC ACID; LINOLENIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE;

ARTICLE; CHILD GROWTH; CHILD NUTRITION; DIET SUPPLEMENTATION; FEMALE; HEAD CIRCUMFERENCE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PREMATURITY; VISUAL ACUITY;

EID: 0029984292     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/63.5.687     Document Type: Article

References (51)

1. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980;4:121-9.
2. Martinez M. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal diseases: severe deficiency of docosahexaenoic acid in Zellweger's and Pseudo-Zellweger's syndromes. In: Simopoulos AP, Kifer RR, Martin RE, Barlow SM, eds. Health effects of omega-3 polyunsaturated fatty acids in seafoods, world review of nutrition and dietetics. Vol 66, Basel, Switzerland: Karger Publishing Press, 1991:87-102.
3. Martinez M, Ballabriga A, Gil-Gibernau JJ. Lipids of the developing human retina: I. Total fatty acids, plasmalogens, and fatty acid composition of ethanolamine and choline phosphoglycerides. J Neurosci Res 1988;20:484-90.
4. Carlson S, Cooke R, Werkman S, Peeples J. Docosahexaenoate (DHA) and eicosapentaenoate (EPA) supplementation of preterm infants (PT). effect on phospholipid DHA and visual acuity. FASEB J 1989;3. A1056(abstr).
5. Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation Am J Clin Nutr 1993;58:35-42.
6. Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992;33:3242-53.
7. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula Lipids 1992;27:901-7.
8. Carlson SE, Cooke RJ, Rhodes PG, Peeples JM, Werkman SH, Tolley EA. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids. Pediatr Res 1991;30:404-12.
9. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993;90:1073-7.
10. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403-8.
11. Dubowitz L, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970;77:1-10.
12. McDonald MA, Dobson V, Sebris SL, Baitch L, Varner D, Teller DY The acuity card procedure: a rapid test of infant acuity. Invest Ophthalmol Vis Sci 1985;26.1158-62.
13. Vistech Consultants, Inc. Teller acuity card handbook. Dayton, OH: Vistech Consultants, Inc, 1990.
14. Courage ML, Adams RJ. Visual acuity assessment from birth to three years using the acuity card procedure: cross-sectional and longitudinal samples. Optom Vis Sci 1990;67:713-8.
15. Teller DY, McDonald MA, Preston K, Sebris SL, Dobson V. Assessment of visual acuity in infants and children: the acuity card procedure. Dev Med Child Neurol 1986;28:779-89.
16. Dobson V. Behavioral tests of visual acuity in infants. Int Ophthalmol Clin 1980;20:233-50.
17. Luna B, Dobson V, Biglan AW. Development of grating acuity in infants with regressed stage 3 retinopathy of prematurity. Invest Ophthalmol Vis Sci 1990;31:2082-7.
18. Dodge JT, Phillips GB. Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. J Lipid Res 1967;8.667-75.
19. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226: 497-509.
20. Zail SS, Pickering A. Fatty acid composition of erythrocytes in hereditary spherocytosis. Br J Haematol 1979;42:339-402.
21. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-8.
22. Carlson SE, Ford AJ, Werkman SH, Peeples JM, Koo WWK. Visual acuity and fatty acid status of term infants fed human milk and formulas with and without docosahexaenoate and arachidonate from egg yolk lecithin. Pediatr Res 1996;39:1-7.
23. Dibley MJ, Goldsby JB, Staehling NW, Trowbridge FL. Development of normalized curves for the international growth reference, historical and technical considerations. Am J Clin Nutr 1987;46:736-48.
24. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-29.
25. SAS Institute, Inc. User's guide: statistics. Version 5 ed. Cary, NC: SAS Institute, Inc, 1985.
26. Sokal RR, Rohlf FJ. Biometry, 2nd ed. New York: WH Freeman, 1981.
27. Searle SR, Speed FM, Milliken GA. Populations marginal means on the linear modei: an alternative to least squares means. Am Statist 1980;34:216-21.
28. Feldman DS, Hofmann R, Gagnon J, Simpson J. StatView II: the solution for data analysis and presentation graphics. Berkeley, CA: Abacus Concepts, 1988.
29. Luna B, Dobson V, Guthrie RD. Grating acuity and visual field development of infants with bronchopulmonary dysplasia. Dev Med Child Neurol 1992;34:813-21
30. Garner A. The role of hyperoxia in the aetiology of retinopathy of prematurity. Doc Ophthalmol 1990;74:187-93.
31. Smart MJ, Walenga RW, Setty BN, Phelps DL. Effects of changes in oxygen tension on lipoxygenase metabolites. Serum 15-HETE is increased in kittens exposed to hyperoxia. Biol Neonate 1990;57:313-7.
32. Groendaal F, van Hof-Van Duin J, Baerts W, Fetter WP. Effects of perinatal hypoxia on visual development during the first year of (corrected) age. Early Hum Dev 1989;20:267-79.
33. Anderson RE, Rapp LM, Wiegand RD. Lipid peroxidation and retinal degeneration. Curr Eye Res 1984;3:223-7.
34. Fliesler SJ, Anderson RE. Chemistry and metabolism of lipids in the venebrate retina. Prog Lipid Res 1983;22:79-131.
35. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992;33:3497-9
36. Reme CE, Malnoe A, Jung HH, Wei P, Munz K. Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina. Invest Ophthalmol Vis Sci 1994;35:78-90.
37. Jensen CL, Chen HM, Smith EO, Prager TC, Heird WC, Anderson RE. Effect of α-linolenic acid (LNA) intake on functional outcomes in term infants. FASEB J 1995;9:A130(abstr).
38. Jensen CL, Chen HM, Prager TC, Anderson RE, Heird WC. Effect of 18:3ω3 intake on plasma fatty acids, growth and visual development of preterm infants. Pediatr Res 1995;37:311A(abstr).
39. Sauerwald T, Jensen CL, Chen HM, Anderson RF, Heird WC, Hachey DL. Effect of dietary 18:3ω3 intake and postnatal age on the kinetics of elongation and desaturation of 18:2ω6 and 18:3ω3. Pediatr Res 1995;37:319A(abstr).
40. Greer FR, McCormick A. Bone mineral content and growth in very-low-birth-weight premature infants. Does bronchopulmonary dysplasia make a difference? Am J Dis Child 1987;141:179-83.
41. Bozynski ME, Albert JM, Vasan U, Nelson MN, Zak LK, Naughton PM. Bronchopulmonary dysplasia and postnatal growth in extremely premature black infants. Early Hum Dev 1990;21:83-92.
42. Markestad T, Fitzhardinge PM. Growth and development in children recovering from bronchopulmonary dysplasia J Pediatr 1981;98:597-602.
43. Suave RS, Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 1985;76:725-33.
44. Peeples JM, Carlson SE, Werkman SH, Cooke RJ. Vitamin A status of preterm infants during infancy. Am J Clin Nutr 1991;53:1455-9.
45. Carlson SE, Peeples JM, Werkman SH, Koo WWK. Plasma retinol and retinol binding protein concentrations in premature infants fed preterm formula past hospital discharge. Eur J Clin Nutr 1995;49: 134-6.
46. Rajaram S, Carlson SE, Koo WWK, Braselton EW. Plasma mineral concentrations in preterm infants fed a nutrient-enriched formula past hospital discharge. J Pediatr 1995;126:791-6.
47. Friel JK, Andrews WL, Matthew JD, et al. Zinc supplementation in very low birth weight infants. J Pediatr Gastroenterol Nutr 1993;17: 97-104.
48. Lucas A, Bishop NJ, King FJ, Cole TJ. Randomized trial of nutrition for preterm infants after discharge. Arch Dis Child 1992;67:324-7.
49. Bishop NJ, King FJ, Lucas A. Increased bone mineral content of preterm infants fed a nutrient enriched formula after discharge from hospital. Arch Dis Child 1993;68 573-8.
50. Carlson SE, Werkman SH, Peeples JM, Wilson WM III. Growth and development of premature infants in relation to ω-3 and ω-6 fatty acid status in fatty acids and lipids: biological aspects. In: Galli C, Simopoulos AP, Tremoli E, eds. World review of nutrition and dietetics. Vol 75. Basel, Switzerland: Karger Publishing Press, 1994:63-9.
51. Carlson SE, Werkman SH. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996;31:85-90.